Autosecreted peptides of VBNC-state Staphylococcus aureus and their applications

By isolating autosecretory peptides from the supernatant of Staphylococcus aureus in the VBNC state, the problem of detecting VBNC state bacteria has been solved, delaying their entry into the unculturable state and improving detection accuracy and window period.

CN116836844BActive Publication Date: 2026-11-17JILIN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310653003.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-06-05
Publication Date
2026-11-17
Estimated Expiration
2043-06-05

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively detect and delay the VBNC state of Staphylococcus aureus, posing a food safety hazard, and the detection window period is short.

Method used

Two autosecreted peptides (peptide 1 and peptide 2) were isolated from the supernatant of Staphylococcus aureus in the VBNC state. Through the action of quorum sensing signaling molecules, they enhanced intracellular enzyme activity, bacterial aggregation and adhesion, and delayed the entry of bacteria into the VBNC state.

Benefits of technology

It delays the entry of Staphylococcus aureus into the VBNC state, improves detection accuracy, extends the detection window period, and enhances the bacteria's tolerance to adversity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116836844B_ABST
    Figure CN116836844B_ABST
Patent Text Reader

Abstract

This invention relates to autosecreted peptides of Staphylococcus aureus in the VBNC state and their applications. Two peptides were isolated from the supernatant of Staphylococcus aureus in the VBNC state, and the effects of these two autosecreted peptides on the formation of the VBNC state in Staphylococcus aureus were studied. Further research was conducted on the applications of these two autosecreted peptides in altering the cell structure of Staphylococcus aureus and improving intracellular enzyme activity, adhesion, and aggregation capabilities. The two autosecreted peptides effectively delayed the entry of Staphylococcus aureus into the VBNC state. Both peptides can enter the cell interior, increasing intracellular enzyme activity. Simultaneously, they enhance the aggregation ability between bacterial cells and the adhesion ability of bacterial cells to object surfaces. In summary, the two autosecreted peptides improve the tolerance of Staphylococcus aureus to adversity, thereby delaying its entry into the VBNC state, gaining time for the detection of Staphylococcus aureus, extending the detection window period, and improving the detection accuracy of Staphylococcus aureus.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to an autosecreted peptide and its application, and particularly to an autosecreted peptide of Staphylococcus aureus in the VBNC state and its application. Background Technology

[0002] Staphylococcus aureus is a common Gram-positive foodborne pathogen widely distributed in nature. It can cause skin, soft tissue, and invasive infections in humans. Currently, Staphylococcus aureus has been found in dairy products, meat products, bread, and soy products. Under certain conditions, Staphylococcus aureus can produce different types of enterotoxins after contaminating food. Ingestion of these toxins can cause food poisoning, leading to symptoms such as diarrhea and general weakness. In recent years, cases of food poisoning caused by Staphylococcus aureus have continued to occur, warranting serious attention.

[0003] In 1982, Xu et al., while studying the survival patterns of Vibrio cholerae and Escherichia coli in marine and estuarine environments, first discovered the viable but nonculturable (VBNC) state. The VBNC state is a special survival strategy adopted by non-spore-forming bacteria in the face of adverse external environments. When bacteria enter the VBNC state under stress, they lose their ability to grow and reproduce on conventional culture media, but some pathogenic bacteria retain a certain degree of pathogenicity. Moreover, when conditions are suitable, VBNC bacteria can revive, regaining culturability and physiological activity. Therefore, when foodborne pathogens in the VBNC state contaminate food, they can escape traditional detection methods. Once these foods are ingested, they may cause illness and harm human health. Viable but nonculturable (VBNC) Staphylococcus aureus can escape traditional culture and detection methods, making it difficult to detect effectively. Furthermore, there are currently no effective methods to delay the entry of Staphylococcus aureus into the VBNC state, resulting in a short detection window and increasing the difficulty of detection. VBNC Staphylococcus aureus also has the potential to revive, posing a potential threat to food safety.

[0004] Studies have shown that bacteria secrete bioactive substances into the environment during their growth and metabolism, including extracellular polysaccharides, peptides, proteins, and virulence factors. Some of these bioactive substances participate in bacterial quorum sensing, affecting bacterial life activities or pathogenicity. However, there is currently limited research on the regulation of bacterial VBNC state by quorum sensing, especially on the VBNC state of Staphylococcus aureus.

[0005] This invention aims to provide an effective detection method and application for preventing foodborne pathogens in the VBNC state, especially Staphylococcus aureus, from the perspective of the influence of quorum sensing signal molecules on the VBNC state of bacteria. Summary of the Invention

[0006] To address the aforementioned technical problems, this invention isolated two peptides from the supernatant of Staphylococcus aureus in the VBNC state and studied the effects of these two autosecreted peptides on the formation of the VBNC state in Staphylococcus aureus. Furthermore, it explores the applications of these two autosecreted peptides in altering the cell structure of Staphylococcus aureus and improving intracellular enzyme activity, adhesion, and aggregation capabilities.

[0007] Neither of the two autologous secreted peptides described herein possesses antimicrobial peptide activity; wherein, the amino acid sequence of peptide 1 is: MKKIVKSSVVTSIALLLLSN; and the amino acid sequence of peptide 2 is: MKMKKLIKSSVASSIALLL.

[0008] Peptide 1 and peptide 2 can enter the interior of Staphylococcus aureus cells and enhance intracellular enzyme activity. Therefore, this invention provides an application of peptide 1 and peptide 2 in enhancing the intracellular enzyme activity of Staphylococcus aureus cells. Specifically, peptide 1 and peptide 2 can be directly added to the Staphylococcus aureus culture medium to enhance intracellular enzyme activity, or peptide 1 and peptide 2 can be used to prepare an active agent for enhancing the intracellular enzyme activity of Staphylococcus aureus. When preparing the active agent for enhancing the intracellular enzyme activity of Staphylococcus aureus, peptide 1 or peptide 2 can be added separately, or peptide 1 and peptide 2 can be added simultaneously.

[0009] Peptide 1 can enhance the aggregation ability between Staphylococcus aureus cells, and peptide 2 can simultaneously enhance both the aggregation ability between Staphylococcus aureus cells and the adhesion ability between the cells and object surfaces. Therefore, this invention provides an application of peptide 1 and peptide 2 in enhancing the aggregation ability between Staphylococcus aureus cells and the adhesion ability between the cells and object surfaces. Specifically, peptide 1 and / or peptide 2 are directly added to Staphylococcus aureus culture medium to enhance the aggregation ability between Staphylococcus aureus cells; or peptide 1 and peptide 2 are directly added to Staphylococcus aureus culture medium, or peptide 2 alone is added, to enhance both the aggregation ability between Staphylococcus aureus cells and the adhesion ability between the cells and object surfaces; or peptide 1 and / or peptide 2 are used to prepare a reagent for enhancing the aggregation ability between Staphylococcus aureus cells; or peptide 1 and peptide 2, or peptide 2 alone, are used to prepare a reagent for enhancing both the aggregation ability between Staphylococcus aureus cells and the adhesion ability between the cells and object surfaces.

[0010] Peptide 1 and peptide 2 can effectively delay the entry of Staphylococcus aureus into the VBNC state. Furthermore, the aforementioned enhancements in intracellular enzyme activity, bacterial aggregation, and adhesion to surfaces all contribute to this delay. Therefore, this invention provides an application of peptide 1 and peptide 2 in delaying the entry of Staphylococcus aureus into the VBNC state. Specifically, peptide 1 and peptide 2 can be directly added to the Staphylococcus aureus culture medium to delay its entry into the VBNC state, or peptide 1 and peptide 2 can be used to prepare a delaying agent for this purpose. When preparing the delaying agent, peptide 1 or peptide 2 can be added separately, or both can be added simultaneously.

[0011] Peptide 1 and peptide 2 may be signaling molecules that enhance the tolerance of Staphylococcus aureus to adversity through quorum sensing, thereby delaying its entry into the VBNC state and providing time for detection. Therefore, this invention provides an auxiliary method for the detection of Staphylococcus aureus, namely, adding a solution of peptide 1 and / or peptide 2 at a final concentration of 0.5-15 μmol / L to the test culture medium before detection to delay the entry of Staphylococcus aureus into the VBNC state and extend the detectable time; the subsequent detection method is prior art and will not be described in detail here.

[0012] The beneficial effects of this invention are:

[0013] This invention, for the first time, isolates two autosecreted peptides from the supernatant of Staphylococcus aureus induced to enter the VBNC state. These peptides enhance the stress tolerance of Staphylococcus aureus through quorum sensing, effectively delaying its entry into the VBNC state. The two autosecreted peptides can enter the cell interior, increasing intracellular enzyme activity. Simultaneously, they enhance the aggregation ability between bacteria and their adhesion to surfaces, thereby delaying the entry into the VBNC state, providing more time for Staphylococcus aureus detection, extending the detection window, and improving the accuracy of Staphylococcus aureus detection. Attached Figure Description

[0014] Figure 1 This is a schematic diagram showing the effect of the supernatant and cells of Staphylococcus aureus in the VBNC state on its own entry into the VBNC state in this invention.

[0015] Figure 2 This is a schematic diagram illustrating the effect of the polypeptide of the present invention on the growth of Staphylococcus aureus;

[0016] Figure 3 This is a schematic diagram of the induction curve of the polypeptide of the present invention on the VBNC state of Staphylococcus aureus;

[0017] Figure 4These are laser confocal micrographs of Staphylococcus aureus in the VBNC state in this invention; group A without peptides, group B with peptide 1, and group C with peptide 2.

[0018] Figure 5 This is a schematic diagram of a transmission electron microscope image of Staphylococcus aureus in this invention;

[0019] Figure 6 This is a schematic diagram of the intracellular enzyme activity of Staphylococcus aureus measured by the API ZYM kit in this invention;

[0020] Figure 7 This invention relates to the effect of the peptides on the adhesion ability of Staphylococcus aureus. The adhesion ability of Staphylococcus aureus induced bacterial suspensions in each group after incubation in 96-well plates for 24 h (A) and 48 h (B) is shown. The adhesion ability of the un-peptide group (C), peptide 1 group (D), and peptide 2 group (E) induced bacterial suspensions after incubation in 96-well plates for 24 h and 48 h is also shown.

[0021] *P<0.05 indicates a significant difference, and ***P<0.001 indicates an extremely significant difference.

[0022] Figure 8 This is a schematic diagram illustrating the mechanism by which peptides 1 and 2 of the present invention delay the formation of VBNC state in Staphylococcus aureus. Detailed Implementation

[0023] The strain used in this embodiment is *Staphylococcus aureus* NCTC 8325-4. To ensure the activity of the experimental strain and the reproducibility of the experiment, the *Staphylococcus aureus* strain needs to be activated before each experiment. *Staphylococcus aureus* strain frozen at -80℃ was purified by streak plating to obtain single colonies. Single colonies were cultured in tryptic soy broth (TSB) medium to obtain a stationary phase culture. This culture was then inoculated into fresh TSB medium at a 1% inoculum and cultured at 37℃ and 200 rpm until the logarithmic growth phase.

[0024] Induction and Influence of VBNC Status in the Supernatant and Cells of Staphylococcus aureus

[0025] The logarithmic-phase bacterial culture was centrifuged at 4℃ and 8000g for 20 min to collect the bacterial precipitate. The precipitate was washed twice with 0.85% NaCl, and finally resuspended in a citrate-disodium hydrogen phosphate buffer solution (pH 4.0) to obtain the induced bacterial culture, achieving a final bacterial concentration of 1×10⁻⁶. 8 The induction solution was incubated at 4°C with CFU / mL.

[0026] The culturable bacterial count in the induced bacterial solution during the transition to the VBNC state was determined using the plate pour method. When the colony count on the plate was less than 1 CFU / mL, the culturable bacterial count in the induced bacterial solution was determined using a 10-fold concentration method until the culturable bacterial count after 10-fold concentration dropped to 0 CFU / mL. At this point, the Staphylococcus aureus in the induced solution had completely entered the VBNC state. Further analysis using SYTO9 / PI bacterial activity assay revealed that a large number of viable bacteria were still present at this stage, indicating that the Staphylococcus aureus in the induced solution had completely entered the VBNC state.

[0027] After the induced bacterial culture had fully entered the VBNC state, it was centrifuged at 4℃ and 8000g for 20 min to obtain the supernatant and bacterial sludge. The supernatant obtained by centrifugation is the supernatant system with 100% VBNC cell content; the bacterial sludge obtained by centrifugation was dissolved in a citrate-disodium hydrogen phosphate buffer solution at pH 4.0 and mixed thoroughly to obtain the bacterial cell system with 100% VBNC cell content; the pure citrate-disodium hydrogen phosphate buffer solution is the system with 0% VBNC cell content. After washing the logarithmic-phase Staphylococcus aureus twice as described above, the bacterial sludge was resuspended in the above three systems to achieve a final concentration of culturable bacteria of 1×10⁻⁶ in each system. 8 The concentration of CFU / mL was measured, and the three induced bacterial cultures were then incubated at 4°C for induction. The number of culturable bacteria was determined using the method described above, with a measurement period of 15 days. This experiment was performed twice.

[0028] like Figure 1 As shown, from day 0 to day 8, the rate of decrease in culturable Staphylococcus aureus count in the induction systems containing 100% VBNC cells or supernatant containing 100% VBNC cells was lower than that in the induction system without either. The induction system containing 100% VBNC cell supernatant showed the slowest rate of decrease in culturable Staphylococcus aureus count. Therefore, it is speculated that Staphylococcus aureus secretes certain substances during the process of entering the VBNC state, thus slowing down the rate of VBNC state formation.

[0029] The method for identifying and synthesizing peptide 1 and peptide 2 described in this invention:

[0030] A supernatant system with 100% VBNC cell content can delay the transition of bacteria to the VBNC state. This invention uses peptidomics to identify potential peptide components in the supernatant. The subjects of identification are three VBNC-state Staphylococcus aureus induction solutions obtained by centrifugation: a freshly induced VBNC state induction solution, an induction solution containing 50% VBNC-state cells, and an induction solution containing only VBNC-state cells. Since salt content may interfere with omics assays, this invention uses a pure citric acid solution as the induction solution. The acquisition time for the three induction solutions is determined based on the induction curve of the pure citric acid induction solution. Figure 3 As shown.

[0031] The three supernatants obtained by centrifugation were freeze-dried under vacuum. Then, an equal volume of protein lysis buffer (8 mol / L urea / 100 mmol / L TEAB, pH 8.0, 1 mmol / L PMSF / 2 mmol / L EDTA) was added to the sample. After mixing, the mixture was incubated on ice for 5 min. DTT was added to a final concentration of 10 mmol / L, and the mixture was sonicated on ice for 15 min. Then, the mixture was centrifuged at 13000g for 30 min at 4°C. The supernatant was collected, and DTT was added to a final concentration of 10 mmol / L. The mixture was then incubated in a water bath at 56°C for 30 min. Subsequently, IAM was added to a final concentration of 55 mmol / L, and the mixture was incubated at room temperature in the dark for 30 min. The mixture was then processed using a 10kD ultrafiltration tube, centrifuged at 10000g for 30 min at 4°C, and the filtrate was collected as the peptide sample. The peptides were desalted using a C18 column, and the desalted peptide fragments were freeze-dried under vacuum. The dried peptide samples were reconstituted with mobile phase A (2% ACN, 0.1% FA), centrifuged at 20,000 g for 10 min, and the supernatant was injected. Separation was performed using an UltiMate 3000U HPLC (Thermo Fisher Scientific, USA). The sample was first enriched and desalted using a trap column, and then eluted in series with a C18 column (75 μm inner diameter, 3 μm column particle size, 25 cm column length) at a flow rate of 300 nl / min under gradient elution conditions of 0–60 min and 5%–80% mobile phase B (98% ACN, 0.1% FA). After HPLC separation, the peptides were ionized using a nanoESI source and then detected in DDA mode using a Q-Exactive HF XMS (Thermo Fisher Scientific, USA). The ion source voltage was 2 kV; the primary mass spectrometry scan range was 350–1500 m / z; the secondary mass spectrometry initial m / z was fixed at 100; and the dynamic exclusion time was 30 s. Data analysis was then performed using MaxQuant software program 1.5.3.30. The criteria for identifying the results were peptide confidence >= 95%, and the identified protein must contain at least one unique peptide. The selected database was the uniprot-taxonomy-Staphylococcus-aureus protein sequence from the uniprot database.

[0032] Sequencing yielded two peptide amino acid sequences, named peptide 1 and peptide 2. The amino acid sequence of peptide 1 is: MKKIVKSSVVTSIALLLLSN; the amino acid sequence of peptide 2 is: MKMKKLIKSSVASSIALLL.

[0033] This invention used ExPASy-PortParam analysis to obtain partial physicochemical properties of these two peptides, and the results are shown in Table 1. It can be seen that the instability coefficients of both peptides are less than 40, therefore they are both stable peptides; peptide 1 is more hydrophobic than peptide 2; both peptides 1 and 2 have high contents of positively charged amino acids, and their isoelectric points are both >10.00. Further, the possible secondary structures of the two peptides were predicted using SOPMA, and the results are shown in Table 2. It can be seen that the secondary structures of peptide 1 and peptide 2 are quite similar, both mainly composed of α-helices and extended chains.

[0034] Table 1. Amino acid sequences and partial physicochemical properties of two polypeptides secreted by Staphylococcus aureus during the formation of the VBNC state.

[0035]

[0036] AA+: Total number of positively charged amino acid residues; AA-: Total number of negatively charged amino acid residues

[0037] Table 2. Secondary structure distribution of the two polypeptides

[0038]

[0039] The two peptides used in the experiment were synthesized by Sangon Biotech (Shanghai) Co., Ltd., with a purity of over 98%.

[0040] Effects of peptides on the growth of Staphylococcus aureus

[0041] Centrifuge the logarithmic-phase Staphylococcus aureus culture at 4℃ and 8000g for 15 min, and then dilute the culture with TSB medium to a concentration of 1×10⁻⁶. 5 CFU / mL. Diluted bacterial cultures were treated with peptide 1 and peptide 2 at final concentrations of 0.5, 2.5, 5, 10, and 15 μmol / L, and then transferred to 96-well plates. A citric acid solution treatment group at pH 4.0 served as a control. The 96-well plates were incubated at 37°C and 200 rpm for 20 h. OD values ​​at 600 nm before and after incubation were measured using a BioTek Synergy HT microplate reader (BioTek Instruments Co., Ltd., USA), and the difference was calculated to obtain the ΔOD600 value. This experiment was performed in triplicate.

[0042] Figure 2The graph shows the trend of ΔOD600 values ​​of Staphylococcus aureus bacterial cultures after adding different concentrations of peptides, reflecting the effect of peptides on the growth of Staphylococcus aureus. The results show that neither of these two peptides inhibited the growth of Staphylococcus aureus; in fact, peptide 1 even showed a certain promoting effect on the growth of Staphylococcus aureus under some concentration conditions. This indicates that neither of these peptides belongs to the category of antimicrobial peptides.

[0043] Effects of peptides on the formation of VBNC status in Staphylococcus aureus

[0044] The VBNC state of Staphylococcus aureus was induced using the method described above. The washed bacterial sludge was resuspended in an induction system of citric acid solution at pH 4.0 with or without peptides 1 and 2. The final bacterial concentration in the induction system was 1 × 10⁻⁶. 8 The concentration of CFU / mL and the final peptide concentration was 5 μmol / L. A pure citric acid solution without added peptide served as a control. The number of culturable bacteria was determined using the pour plate method to ascertain the time required for complete transition to an unculturable state. This experiment was performed in triplicate.

[0045] The trends of culturable Staphylococcus aureus counts with induction time in citric acid solutions at pH 4.0 at 4℃ and in citric acid solutions containing two peptides with a final concentration of 5 μmol / L are shown in the figure below. Figure 3 As shown in the figure. It was found that the culturable bacterial count in the control group without added peptides dropped to an undetectable level (<0.1 CFU / mL) on day 29, while the culturable bacterial counts in the groups with added peptides 1 and 2 dropped to the same level on days 53 and 59, respectively. The survival status of Staphylococcus aureus in each group at this time is shown in the figure. Figure 4 As shown, green fluorescence represents live bacteria, and red fluorescence represents dead bacteria. Live bacteria were present in both the induced bacterial cultures without and with both peptides, indicating that all three induced bacterial cultures entered the VBNC state. This demonstrates that peptides 1 and 2 significantly inhibited the formation of the VBNC state in Staphylococcus aureus induced by citric acid at 4°C. The total average hydrophobicity coefficients of peptides 1 and 2 were positive, indicating that they are hydrophobic peptides. Furthermore, they both possess the α-helical structure common to many membrane proteins, which may facilitate their interaction with bacterial cells, thereby altering the ability of Staphylococcus aureus to form the VBNC state. The bacterial clumps formed after the action of peptides 1 and 2 (…) Figure 4 B and 4C also indicate that there is a certain interaction between them and the bacterial cells.

[0046] Effects of peptides on the internal structure of Staphylococcus aureus

[0047] This invention uses transmission electron microscopy to observe the internal structure of Staphylococcus aureus in the logarithmic phase and various VBNC states induced by different systems. For example... Figure 5As shown in (A) to (D), the cell walls and cell membranes of Staphylococcus aureus in the logarithmic growth phase are intact, smooth, and tightly adhered. The contents of the cytoplasm are clearly visible, the nucleus is distinct, and the electron density of the nucleus is lower than that of the cytoplasm. Figure 5 A to Figure 5 D shows different stages of Staphylococcus aureus binary fission. For example... Figure 5 As shown in (E) to (H), in Staphylococcus aureus induced into the VBNC state by pure citric acid solution, the boundaries between the cell wall and cell membrane remain relatively clear, but the electron density of the cytoplasm is significantly increased, making inclusions indistinguishable. The electron density in the nucleus region is also increased, making it difficult to distinguish. Furthermore, some cells exhibit highly transparent vacuoles between the cell wall and cell membrane, while others show vacuoles between the cell wall and cell membrane in the intermediate septum. It is noteworthy that some cells show a bright area exceeding 50% within their interior, and the electron density of the cytoplasm is lower than that of cells in the logarithmic growth phase; these cells are considered dead cells. Figure 5 H).

[0048] like Figure 5 As shown in (I) to (P), after entering the VBNC state, the Staphylococcus aureus cells of peptide groups 1 and 2 exhibited blurred cell wall and cell membrane boundaries, with most cells showing an uneven cell wall surface. The cytoplasm also showed increased electron density, with group 2 showing a higher electron density than group 1. The uneven cell wall may be one reason for the aggregation of the cells caused by the two peptides. Compared to VBNC cells without added peptides, the VBNC cells of peptide groups 1 and 2 showed more pronounced vacuoles between the cell wall and cell membrane, and the vacuoles between the transverse septum and cell membrane were also larger. Notably, both peptide groups showed blade breakage during the slicing process. Combined with the presence of numerous vacuoles, it is speculated that peptides 1 and 2 can penetrate the bacterial cell interior.

[0049] Effects of peptides on intracellular enzyme activity in Staphylococcus aureus

[0050] Treatment with peptides 1 and 2 helps maintain the culturability of the bacteria and delays the formation of the VBNC state. Because enzymes play a crucial role in all life activities of microorganisms, this invention further measured the intracellular enzyme activities of the peptide-treated and untreated groups, and the results are as follows: Figure 6As shown, the activities of six enzymes were detected in logarithmic growth phase cells, including alkaline phosphatase (No. 2), esterase (No. 3), lipolipase (No. 4), acid phosphatase (No. 11), naphthol-AS-BI-phosphohydrolase (No. 12), and α-glucosidase (No. 16). In VBNC cells without added peptides, the activities of five intracellular enzymes were detected: alkaline phosphatase (No. 2), esterase (No. 3), lipolipase (No. 4), acid phosphatase (No. 11), and naphthol-AS-BI-phosphohydrolase (No. 12), and the activities of all enzymes were decreased. This decrease in enzyme activity reduces the cellular metabolic level, making the cells more susceptible to entering an unculturable state, which may be one of the reasons for the formation of the VBNC state.

[0051] The enzyme activities detected in VBNC cells of peptide groups 1 and 2 were higher than those in the logarithmic phase. The activities of 12 enzymes were detected in VBNC cells of peptide group 1: alkaline phosphatase (No. 2), esterase (No. 3), lipoesterase (No. 4), valine arylamidinase (No. 7), acid phosphatase (No. 11), naphthol-AS-BI-phosphohydrolase (No. 12), β-galactosidase (No. 14), α-glucosidase (No. 16), β-glucosidase (No. 17), N-acetyl-glucosaminease (No. 18), α-mannosidase (No. 19), and α-fucosidase (No. 20). Ten enzyme activities were observed in VBNC cells of peptide 2 group: alkaline phosphatase (No. 2), esterase (No. 3), lipolipase (No. 4), valine arylamidinase (No. 7), cystine arylamidinase (No. 8), acid phosphatase (No. 11), naphthol-AS-BI-phosphohydrolase (No. 12), β-galactosidase (No. 14), β-glucosidase (No. 17), and α-fucosidase (No. 20). It can be seen that the intracellular enzyme activities of Staphylococcus aureus with the addition of peptide 1 and peptide 2 were increased, which maintains high metabolic activity within the cell, making the cells less prone to losing culturability and thus delaying the formation of the VBNC state.

[0052] The above results indicate that peptide 1 and peptide 2 can enter the interior of Staphylococcus aureus cells, increase intracellular enzyme activity, and thus delay the entry of Staphylococcus aureus into the VBNC state under low pH and low temperature conditions.

[0053] Effects of peptides on the adhesion and aggregation ability of Staphylococcus aureus

[0054] The previous results showed that peptide 1 was more effective than peptide 2 in increasing the intracellular enzyme activity of Staphylococcus aureus; however, peptide 2 was more effective than peptide 1 in delaying the entry of Staphylococcus aureus into the VBNC state. Studies have shown that bacterial adhesion decreases after entering the VBNC state. Crystal violet staining can measure the adhesion ability of bacteria to object surfaces; therefore, this invention used crystal violet staining to determine the adhesion ability of Staphylococcus aureus after incubation in 96-well plates for 24 h and 48 h at different induction times, to further explore the mechanism by which peptides 1 and 2 delay the entry of Staphylococcus aureus into the VBNC state. Figure 7 As shown in (A) to (B), in the early stage of induction, the adhesion ability of the induced bacterial culture in group 1 was not significantly different from that in the group without peptide. However, by day 28 of induction, its adhesion ability was significantly lower than that in the group without peptide. The adhesion ability of group 2 was higher than that in the group without peptide, and this difference was extremely significant throughout the 28-day induction period (P < 0.001). Further analysis was conducted on the adhesion ability of each induced bacterial culture at different incubation times. Figure 7 As shown in (C) to (E), the adhesion ability of the induced bacterial cultures in the untreated group and the peptide 1 group after 24 h and 48 h of incubation showed no significant difference throughout the 28-day induction period. However, starting from day 7 of induction, the adhesion ability of the peptide 2 group after 48 h of incubation was significantly higher than that after 24 h of incubation. These results indicate that *Staphylococcus aureus* treated with peptide 2 has a stronger adhesion ability to object surfaces and a greater adhesion potential; the bacterial adhesion process was not fully completed even after 24 h of incubation. These results suggest that peptide 2 can improve the adhesion ability of *Staphylococcus aureus* to object surfaces, which is beneficial for resisting adverse conditions such as low pH, thereby delaying its entry into the VBNC state.

[0055] exist Figure 4 In the laser confocal images (B) and (C), bacterial aggregation was observed in both peptide 1 and peptide 2 groups. Combined with the crystal violet staining results, this indicates that peptide 1 enhances the aggregation ability between bacterial cells, while peptide 2 simultaneously enhances both the aggregation ability between bacterial cells and their adhesion to surfaces. This improved aggregation and adhesion help protect *Staphylococcus aureus* from environmental damage, making it less likely for the bacteria to lose culturability, thus exhibiting a delaying effect on the formation of the VBNC state. However, peptide 1 does not enhance the adhesion of *Staphylococcus aureus* to surfaces. This explains why, even though the intracellular enzyme activity after peptide 1 treatment was higher than that of peptide 2, peptide 2 still had a better delaying effect on *Staphylococcus aureus* entering the VBNC state than peptide 1.

[0056] The final peptide concentration used in the experiments described above was 5 μmol / L. Peptide concentrations of 0.5 μmol / L, 2.5 μmol / L, 10 μmol / L, and 15 μmol / L can also achieve similar effects.

[0057] In summary, this invention, for the first time, isolated two peptides from the supernatant induced by Staphylococcus aureus to enter the VBNC state. Neither peptide possesses antimicrobial peptide activity, but both can effectively delay the entry of Staphylococcus aureus into the VBNC state. Peptide 1 and peptide 2 can enter the cell interior and increase intracellular enzyme activity. Simultaneously, peptide 1 can enhance the aggregation ability between bacterial cells, while peptide 2 can simultaneously enhance both the aggregation ability between bacterial cells and the adhesion ability of bacterial cells to object surfaces. Figure 8 The above changes all contribute to delaying the entry of cells into the VBNC state. This invention concludes that peptide 1 and peptide 2 may be signaling molecules that enhance the tolerance of Staphylococcus aureus to adversity through quorum sensing, thereby delaying its entry into the VBNC state. This provides more time for the detection of Staphylococcus aureus. Therefore, this invention proposes an auxiliary method for the detection of Staphylococcus aureus, namely, adding peptide 1 and / or peptide 2 solutions with final concentrations of 0.5, 2.5, 5, 10, and 15 μmol / L to the test solution before Staphylococcus aureus detection to delay the entry of Staphylococcus aureus into the VBNC state, thereby increasing the detectable time, extending the detection window period, and improving the detection accuracy of Staphylococcus aureus.

Claims

1. Use of an autosecreted peptide of VBNC state Staphylococcus aureus, characterized in that: The autologous secreted peptides include peptide 1 and peptide 2. The amino acid sequence of peptide 1 is: MKKIVKSSVVTSIALLLLSN; the amino acid sequence of peptide 2 is: MKMKKLIKSSVASSIALLL; the application is as follows: Used to enhance the intracellular enzyme activity of Staphylococcus aureus cells; Or it can be used to improve the aggregation ability between Staphylococcus aureus cells and the adhesion ability of cells to object surfaces; Or it can be used to delay the entry of Staphylococcus aureus into the VBNC state; Or it can be used for the detection of Staphylococcus aureus for purposes other than disease diagnosis and treatment.

2. Use of an autolysin peptide of VBNC state Staphylococcus aureus according to claim 1, characterized in that: Adding peptide 1 and / or peptide 2 directly to Staphylococcus aureus culture medium can enhance the intracellular enzyme activity of Staphylococcus aureus cells, or using peptide 1 and / or peptide 2 to prepare activators for enhancing the intracellular enzyme activity of Staphylococcus aureus.

3. The application of the autosecretory peptide of Staphylococcus aureus in VBNC state according to claim 1, characterized in that: Peptide 1 can enhance the aggregation ability between Staphylococcus aureus cells, while peptide 2 can enhance both the aggregation ability between Staphylococcus aureus cells and the adhesion ability of cells to object surfaces.

4. The application of the autosecretory peptide of Staphylococcus aureus in VBNC state according to claim 1 or 3, characterized in that: Adding peptide 1 and / or peptide 2 directly to Staphylococcus aureus culture medium can enhance the aggregation ability between Staphylococcus aureus cells; or adding peptide 1 and peptide 2 directly or peptide 2 alone to Staphylococcus aureus culture medium can enhance the aggregation ability between Staphylococcus aureus cells and the adhesion ability of cells to object surfaces; or using peptide 1 and / or peptide 2 to prepare reagents for enhancing the aggregation ability between Staphylococcus aureus cells. Alternatively, peptide 1 and peptide 2, or peptide 2 alone, can be used to prepare reagents that enhance the aggregation ability between Staphylococcus aureus cells and the adhesion ability of cells to object surfaces.

5. The application of the autosecretory peptide of Staphylococcus aureus in VBNC state according to claim 1, characterized in that: Adding peptide 1 and / or peptide 2 directly to the Staphylococcus aureus culture medium can delay the entry of Staphylococcus aureus into the VBNC state, or using peptide 1 and / or peptide 2 to prepare a delaying agent for delaying the entry of Staphylococcus aureus into the VBNC state.

6. An auxiliary method for detecting Staphylococcus aureus, characterized in that: The method is used for the detection of Staphylococcus aureus for non-disease diagnosis and treatment purposes. Before the detection of Staphylococcus aureus, a solution of peptide 1 and / or peptide 2 with a final concentration of 0.5-15 μmol / L is added to the culture medium to delay the entry of Staphylococcus aureus into the VBNC state. The amino acid sequence of peptide 1 is: MKKIVKSSVVTSIALLLLSN; the amino acid sequence of peptide 2 is: MKMKKLIKSSVASSIALLL.